14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 300529.SZ
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Jafron Biomedical Co Ltd stock price up 0.451% on Friday
(Updated on May 17, 2024)

Hold candidate since May 16, 2024 Gain 0.45% PDF

The Jafron Biomedical Co Ltd stock price gained 0.451% on the last trading day (Friday, 17th May 2024), rising from ¥28.80 to ¥28.93. During the last trading day the stock fluctuated 1.64% from a day low at ¥28.61 to a day high of ¥29.08. The price has been going up and down for this period, and there has been a 5.05% gain for the last 2 weeks. Volume fell on the last day by -3 million shares and in total, 6 million shares were bought and sold for approximately ¥162.42 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.77% during the next 3 months and, with a 90% probability hold a price between ¥33.58 and ¥42.25 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

300529.SZ Signals & Forecast

The Jafron Biomedical Co Ltd stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately ¥29.37. On a fall, the stock will find some support from the long-term average at approximately ¥24.95. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 14, 2024, and so far it has fallen -5.05%. Further fall is indicated until a new bottom pivot has been found. The stock had a Golden Star Signal on Monday, April 22, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Monday, April 22, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Jafron Biomedical Co Ltd stock

Jafron Biomedical Co Ltd finds support from accumulated volume at ¥27.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved ¥0.470 between high and low, or 1.64%. For the last week, the stock has had daily average volatility of 3.79%.

Our recommended stop-loss: ¥27.58 (-4.66%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 78 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (300529.SZ) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Jafron Biomedical Co Ltd to open at ¥28.87, and during the day (based on 14 day Average True Range), to move between ¥27.31 and ¥30.55, which gives a possible trading interval of +/-¥1.62 (+/-5.61%) up or down from last closing price. If Jafron Biomedical Co Ltd takes out the full calculated possible swing range there will be an estimated 11.22% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at ¥29.09 (0.55%) than the support at ¥27.54 (4.80%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Jafron Biomedical Co Ltd stock A Buy?

Jafron Biomedical Co Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.592 Hold/Accumulate Unchanged

Predicted Opening Price for Jafron Biomedical Co Ltd of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
¥28.87 ( 0.196%) ¥28.93

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 300529.SZ

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 29.34 1.43 %
R2 29.16 0.81 %
R1 29.05 0.425 %
Current price: 28.93
Support S1 28.69 -0.82 %
S2 28.58 -1.20 %
S3 28.40 -1.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 30.47 5.32 %
R2 29.41 1.66 %
R1 29.09 0.553 %
Current price 28.93
Support S1 27.54 -4.80%
S2 27.10 -6.33%
S3 26.15 -9.61%

300529 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 31, 2023 May 31, 2023 May 31, 2023 ¥0.670 2.42%
2 Jun 10, 2022 Jun 10, 2022 Jun 10, 2022 ¥0.90 1.94%
3 May 12, 2021 May 12, 2021 May 12, 2021 ¥0.660 0.694%
4 May 20, 2020 May 20, 2020 May 20, 2020 ¥0.474 0.777%
5 May 13, 2019 May 13, 2019 May 13, 2019 ¥0.316 0.97%

FAQ

What is the symbol for Jafron Biomedical Co Ltd Stock and on which exchange is it traded?
The symbol for Jafron Biomedical Co Ltd is 300529.SZ and it is traded on the SZCE (Shenzhen Stock Exchange).

Should I buy or sell Jafron Biomedical Co Ltd Stock?
Jafron Biomedical Co Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Jafron Biomedical Co Ltd Stock?
Jafron Biomedical Co Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Jafron Biomedical Co Ltd Stock.

What's the current price of Jafron Biomedical Co Ltd Stock?
As of the end of day on the May 17, 2024, the price of an Jafron Biomedical Co Ltd (300529.SZ) share was ¥28.93.

What is the 52-week high and low for Jafron Biomedical Co Ltd Stock?
The 52-week high for Jafron Biomedical Co Ltd Stock is ¥30.65 and the 52-week low is ¥15.88.

What is the market capitalization of Jafron Biomedical Co Ltd Stock?
As of the May 17, 2024, the market capitalization of Jafron Biomedical Co Ltd is 23.548B.

When is the next earnings date for Jafron Biomedical Co Ltd?
The upcoming earnings date for Jafron Biomedical Co Ltd is May 20, 2024.
Click to get the best stock tips daily for free!

About Jafron Biomedical Co Ltd

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. It offers solutions for kidney, liver, critical, and rheumatism diseases, as well as poisoning; adsorption products and blood purification machines; and other products, such as single use arteriovenous puncture, hemodialysis online dry powder bags/cylinders, disinfectants, hemodialysis concentrates, and ... 300529.SZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT